Pharma Blister Films - PVdC: Market Size & Forecast 2026

The global pharma blister films market anchored by polyvinylidene chloride (PVdC) coating technology reached approximately USD 0.85 billion in 2025, underpinned by a 5.8% CAGR through 2032 as moisture-barrier specifications tighten across regulated pharmaceutical markets. PVdC-coated films command roughly 62% of the specialist segment, with cold-form aluminium foil and thermoformable structures sharing the remainder. The dominant demand driver is tablet and capsule blister packaging at 71% of end-use, a segment that tracks chronic disease burden and generic drug launch cadence more than macroeconomic cycles. On the supply side, PVdC resin (pharma-grade latex) accounts for approximately 48% of finished film cost, placing buyer procurement strategy at the intersection of specialty polymer pricing and regulatory qualification timelines that routinely stretch 9 to 18 months. The 2026 trade e

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.